홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 메디컬디바이스 > The Home Medical Equipment Market
카테고리
메디컬디바이스 (4663)
내시경 (161)
분자영상/조영제 (28)
심혈관장치 (336)
안과기기 (102)
의료용 영상진단장치 (416)
의료용 일회용품 (77)
정형외과 (340)
창상관리 (163)
체외진단장치(IVD) (520)
초음파 (55)
치과기기 (176)
카테터 (239)
핵의료 (76)
헬스케어 IT (315)
환자모니터링 (390)
CT/MRI/X-ray (173)
시장보고서

The Home Medical Equipment Market

리서치사 BCC Research
발행일 2007년 10월 상품코드 57384
페이지 정보 147 pages; 41 tables
가격
US $ 4,850 ￦ 5,778,700 PDF by E-mail (Single User License)
US $ 5,950 ￦ 7,089,400 PDF by E-mail (Business Unit License)
US $ 8,500 ￦ 10,127,700 PDF by E-mail (Enterprise License)


영문목차

Abstract

INTRODUCTION

Home medical equipment (HME) is a multibillion dollar market that is poised for rapid growth as the population ages and as growing number of older people are financially able to live in their own homes for as long as possible, rather than going into a nursing home or other institutional care facility. These demographic and attitudinal shifts in the health care market are reinforced by such trends as the rising cost of institutional care, and a growing receptivity to home health care among physicians and private and public insurers.

SCOPE OF STUDY

This report contains:

  • Descriptions of the main types of home medical equipment (HME) that have been commercialized to date including assistive devices, therapeutic devices, monitors, sensors and telemetry devices
  • The current market status of HME, trends and forecasts for growth over the next 5 years
  • A discussion of novel technologies along with a thorough patent analysis
  • An evaluation of regulatory factors that will drive future demand in the industry
  • Information about major manufacturers and distributors of HME.

INFORMATION SOURCES

The findings and conclusions of this report are based on information gathered from manufacturers and distributors of HME, multi-lateral and government agencies, care givers, insurance companies, and other knowledgeable sources. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and on-line databases to produce the baseline market estimates contained in this report.

The base-year for analysis and projection is 2006. With 2006 as a baseline, market projections were developed for 2007 to 2012. These projections are based on a combination of a consensus among the primary contacts combined with our understanding of the key market drivers and their impact from a historical and analytical perspective. The analytical methodologies used to generate the market estimates are described in detail in the section on Detailed Market Projections.

All dollar projections presented in this report are in 2006 constant dollars.

Table of Contents

  • Chapter 1 - EXECUTIVE SUMMARY
    • Summary Table: GLOBAL SALES OF HOME MEDICAL EQUIPMENT, THROUGH 2012 ($ BILLIONS)
    • Summary Figure: SALES OF HOME MEDICAL EQUIPMENT BY REGION, 2006-2012 (%)
  • Chapter 2 - OVERVIEW
    • GENERAL DESCRIPTION
      • DEFINITIONS
    • PRODUCT SEGMENTS
      • ASSISTIVE DEVICES
        • Wheelchairs and Scooters
          • Wheelchairs
          • Scooters
        • Home Care Beds
      • INFUSION PRODUCTS
        • Insulin Pumps
          • RESPIRATORY THERAPY PRODUCTS
        • Inhalers
          • Metered Dose Inhalers
          • Dry Powder Inhalers
        • Nebulizers
        • Oxygen Concentrators
        • Gaseous Oxygen System
        • Continuous Positive Airway Pressure (CPAP) Devices
        • Home Ventilators
        • Suction Machines
      • DIALYSIS EQUIPMENT
        • Hemodialysis
          • Dialysis Machine
        • Peritoneal Dialysis
          • CCPD Cycler
      • HOME DEFIBRILLATORS
      • MONITORS AND SENSORS
        • Blood Pressure Monitors
          • Aneroid Monitors
          • Digital Blood Pressure Monitors
        • Peak Flow Meters
        • Glucose Monitors
          • Glucose Monitors (Continued)
          • Glucose Monitors (Continued)
        • Apnea and SIDS Monitors
        • Cholesterol Monitors
        • Fetal Monitors
        • Home Cardiac Monitors
        • New Home Monitoring Technologies
          • Embedded Monitors
          • Wearable Monitors
      • TELEMETRY DEVICES
        • Telehomecare
        • Mobile Phone-Based Technologies
        • Bluetooth
        • Signal Transmission via Human Skin
        • Zigbee
      • MISCELLANEOUS TYPES OF HME
        • Lymphedema Pumps
      • HEALTH CONDITIONS THAT AFFECT MARKET FOR HME
        • MOBILITY IMPAIRMENTS
          • Types of Mobility Impairment
            • Paralysis
            • Arthritis
            • Osteoporosis
            • Age-Related Loss of Strength/Balance/Coordination
            • Surgical Recovery and Rehabilitation
            • Neuromuscular Disorders
          • HME Used to Increase Mobility
          • Prevalence of Mobility Impairments
    • Figure 1 LEADING CONDITIONS ASSOCIATED WITH WHEELCHAIR/SCOOTER USE (PERCENTAGE OF TOTAL WHEELCHAIR USERS
    • Figure 1 (CONTINUED)
    • Table 1 GLOBAL PREVALENCE OF MOTION IMPAIRMENTS REQUIRING THE USE OF A WHEELCHAIR OR SCOOTER, THROUGH 2012 (MILLIONS OF PEOPLE)
    • Table 1 (CONTINUED)
    • Table 2 PREVALENCE OF MOTION IMPAIRMENTS REQUIRING A WHEELCHAIR OR SCOOTER, BY REGION, THROUGH 2012 (MILLIONS OF PEOPLE)
      • OBESITY
        • HME Used in the Management of Obesity
        • Prevalence of Obesity
    • Table 3 OBESITY LEVELS IN SELECTED COUNTRIES (PERCENT OF ADULT POPULATION)
    • Table 3 (CONTINUED)
      • HYPERTENSION
        • Types of HME Used in Treatment of Hypertension
        • Prevalence of Hypertension
    • Table 4 TRENDS IN PREVALENCE OF HYPERTENSION, THROUGH 2012 (MILLION CASES)
    • Table 4 (CONTINUED)
      • CARDIOVASCULAR DISEASE
        • Arrhythmia
          • Tachyarrhythmia
          • Brachycardia
        • HME Used in the Treatment of Arrhythmia
        • Prevalence of Arrhythmia
    • Table 5 TRENDS IN PREVALENCE OF ARRYTHMIA, THROUGH 2012 (MILLIONS OF CASES)
      • DIABETES
        • Types of Diabetes
        • HME Used to Treat Diabetes
        • Prevalence of Diabetes and Future Trends
    • Table 6 TRENDS IN PREVALENCE OF DIABETES, THROUGH 2012 (MILLIONS OF CASES)
    • Table 6 (CONTINUED)
      • HIGH CHOLESTEROL LEVELS
        • HME Used in the Management of High Cholesterol Levels
        • Prevalence of High Cholesterol Levels
      • SLEEP DISORDERS
        • Types of Sleep Disorders
        • HME Used in the Treatment or Management of Sleep Disorders
        • Prevalence of Sleep Disorders and Future Trends
      • FETAL DISORDERS
        • HME Used in the Treatment or Management of Fetal Disorders
        • Prevalence of Fetal Disorders and Future Trends
    • Figure 2 MISCARRIAGES AND STILLBIRTHS IN THE UNITED STATES, 2004 (PERCENT OF TOTAL CONFIRMED PREGNANCIES)
      • ASTHMA
        • HME Used in the Treatment or Management of Asthma
        • Prevalence of Asthma and Future Trends
    • Table 7 TRENDS IN PREVALENCE OF ASTHMA, THROUGH 2012 (MILLION CASES)
      • CHRONIC OBSTRUCTIVE PULMONARY DISEASE
        • HME Used in the Treatment or Management of COPD
        • Prevalence of COPD and Future Trends
      • KIDNEY FAILURE
        • HME Used in the Treatment of Kidney Failure
        • Prevalence of Kidney Failure and Future Trends
    • Table 8 TRENDS IN DIALYSIS PATIENT POPULATION, THROUGH 2012 (THOUSAND PEOPLE)
    • Table 8 (CONTINUED)
    • Figure 3 GLOBAL DIALYSIS PATIENT POPULATION TREND, 2006-2012 (MILLION PATIENTS)
      • LYMPHEDEMA
        • Types of Lymphedema
          • Primary Lymphedema
          • Secondary Lymphedema
        • HME Used in the Management of Lymphedema
        • Prevalence of Lymphedema
      • DEMOGRAPHICS AND ECONOMICS
        • TOTAL POPULATION
    • Figure 4 GLOBAL POPULATION TRENDS, 2006-2012 (BILLION PEOPLE)
    • Figure 5 G-20 POPULATION AS PERCENTAGE OF TOTAL WORLD POPULATION, 2006 AND 2012 (%)
    • Table 9 TRENDS IN TOTAL POPULATION, BY COUNTRY THROUGH 2012 (MILLIONS)
    • Table 9 (CONTINUED)
      • ELDERLY PEOPLE
    • Figure 6 TRENDS IN THE GLOBAL POPULATION AGED 65 YEARS AND OLDER, 2006-2012 (MILLION PEOPLE)
    • Figure 7 G-20 POPULATION AS PERCENTAGE OF WORLD POPULATION 65 AND OLDER, 2006 AND 2012 (%)
    • Table 10 TRENDS IN POPULATION 65 YEARS AND OLDER, BY COUNTRY THROUGH 2012 (MILLIONS)
    • Table 10 (CONTINUED)
      • OLDER PEOPLE LIVING IN OWN HOMES OR WITH CHILDREN
    • Figure 8 PERCENTAGE OF PEOPLE 65 AND OVER LIVNG IN OWN HOMES OR WITH CHILDREN, 2002
    • Figure 8 (CONTINUED)
    • Figure 9 TRENDS IN THE PERCENTAGE OF AMERICANS OVER 65 REMAINING IN THEIR HOMES, 1985-2005 (%)
      • HOUSEHOLD INCOME
    • Figure 10 TRENDS IN MEDIAN INCOME OF U.S. ELDERLY HOUSEHOLDS ($)
    • Figure 11 DISTRIBUTION OF U.S. ELDERLY HOUSEHOLDS BY INCOME LEVEL, 2000 VS. 2006 (PERCENT OF TOTAL ELDERLY HOUSEHOLDS)
      • EXPENDITURES ON HOME HEALTH CARE
    • Figure 12 TRENDS IN U.S. EXPENDITURES ON HOME HEALTH CARE, 2000-2005* ($ BILLIONS)
      • OTHER FACTORS DRIVING HME MARKET
        • PHYSICIAN ATTITUDES TOWARD HOME CARE
    • Figure 13 TREND IN NUMBER OF MEDICARE-PAID PHYSICIAN HOUSE CALLS, 2001-2005 (MILLION HOUSE CALLS)
      • HOSPITAL/ NURSING HOME COSTS
    • Figure 14 TRENDS IN U.S. HOSPITAL AND NURSING HOME COSTS SINCE 2000 ($)
      • REGULATORY AND LEGISLATIVE ISSUES
        • United States
          • New Devices
            • New Devices (Continued)
          • Existing Devices
        • European Union
          • European Union (Continued)
        • Japan
      • HEALTH INSURANCE
        • United States
          • Medicare and Medicaid
          • Types of HME Covered
          • Recent Legislation
            • Medicare Prescription Drug, Improvement, and Modernization Act of 2003
            • Changes in Reimbursement
            • Competitive Bidding
            • Accreditation Requirement
            • Deficit Reduction Act of 2005
            • Challenges
          • Other Countries
    • Figure 15 PER CAPITA EXPENDITURES ON HME, 2006 ($)
      • Other Countries (Continued)
  • Chapter 3 - HME MARKETS
    • SUMMARY
      • GLOBAL MARKET TRENDS
    • Table 11 GLOBAL HME SALES BY TYPE OF EQUIPMENT, THROUGH 2012 ($ MILLIONS)
    • Figure 16 TRENDS IN THE GLOBAL HME MARKET, 2006-2012($ BILLIONS)
      • MARKET BY HME SEGMENT
    • Figure 17 HME MARKET BY TYPE OF HME, 2006 AND 2012 (%)
      • MARKET BY DISEASE/ CONDITION TREATED
    • Figure 18 HME MARKET BY TYPE OF DISEASE/CONDITION TREATED, 2006 AND 2012
    • Figure 18 (CONTINUED)
    • Table 12 HME MARKET BY TYPE OF DISEASE/CONDITION TREATED, THROUGH 2012 ($ MILLIONS)
      • MARKET BY GEOGRAPHICAL SEGMENT
    • Figure 19 HME MARKET BY TYPE OF REGION, 2006 AND 2012 (%)
    • Figure 19 (CONTINUED)
    • Table 13 MAJOR GEOGRAPHICAL MARKETS FOR HME, THROUGH 2012
    • Table 13 (CONTINUED)
      • DETAILED MARKET ANALYSIS
        • ASSISTIVE DEVICES
    • Table 14 MARKET FOR HME ASSISTIVE DEVICES, THROUGH 2012 ($ MILLIONS)
      • Wheelchairs and Scooters
    • Figure 20 GLOBAL WHEELCHAIR AND SCOOTER MARKET SHARES BY TYPE OF EQUIPMENT, 2006 (%)
    • Figure 20 (CONTINUED)
    • Table 15 GLOBAL WHEELCHAIR AND SCOOTER SALES, 2006 (MILLION UNITS/$ MILLIONS)
    • Table 16 GLOBAL MARKET FOR WHEELCHAIRS AND SCOOTERS USED IN THE HOME, BY GEOGRAPHICAL MARKET, 2006-2012 ($ MILLIONS)
      • Home Care Beds
    • Table 17 GLOBAL MARKET FOR HOME CARE BEDS, BY GEOGRAPHICAL MARKET, THROUGH 2012 ($ MILLIONS)
      • INFUSION PRODUCTS
        • Insulin Pumps
    • Table 18 INSULIN PUMP SALES, THROUGH 2012 (NUMBER OF PUMPS/$ MILLIONS)
    • Table 19 PROJECTED SALES OF INSULIN PUMPS, THROUGH 2012 ($ MILLIONS)
      • RESPIRATORY THERAPY PRODUCTS
    • Table 20 MARKET FOR RESPIRATORY HME, THROUGH 2012 ($ MILLIONS)
    • Figure 21 TRENDS IN RESPIRATORY HME MARKET SHARES BY TYPE OF EQUIPMENT, 2006-2012 (PERCENT OF TOTAL RESPIRATORY HME SALES)
    • Figure 22 TRENDS IN RESPIRATORY HME MARKET SHARES BY GEOGRAPHICAL MARKET, 2006-2012 (PERCENT OF TOTAL RESPIRATORY HME SALES)
      • Insulin Inhalers
    • Table 21 PROJECTED SALES OF INSULIN INHALERS, THROUGH 2012 ($ MILLIONS)
    • Table 21 (CONTINUED)
      • CPAP and Other Positive Airway Pressure Devices
    • Table 22 POSITIVE AIR PRESSURE DEVICES MARKET, THROUGH 2012 ($ MILLIONS)
    • Table 22 (CONTINUED)
      • Ventilators
    • Table 23 GLOBAL HOME VENTILATOR MARKET, THROUGH 2012 ($ MILLIONS)
      • Nebulizers
    • Table 24 GLOBAL NEBULIZER MARKET, THROUGH 2012 ($ MILLIONS)
      • Oxygen Concentrators
    • Table 25 GLOBAL HOME OXYGEN CONCENTRATOR MARKET, THROUGH 2012 ($ MILLIONS)
      • Gaseous Oxygen Systems
    • Table 26 GLOBAL MARKET FOR HOME GASEOUS OXYGEN SYSTEMS, THOUGH 2012 ($ MILLIONS)
      • Airway Suction Machines
    • Table 27 GLOBAL HOME SUCTION MACHINE MARKET, THROUGH 2012 ($ MILLIONS)
      • DIALYSIS EQUIPMENT
    • Figure 23 HOME DIALYSIS MACHINE MARKET SHARES, 2006 (%)
    • Table 28 GLOBAL MARKET FOR HOME DIALYSIS MACHINES, 2006 (NUMBER OF MACHINES/$)
    • Table 29 HOME DIALYSIS MACHINE MARKET, THROUGH 2012 ($ MILLIONS)
    • Table 29 (CONTINUED)
      • HOME DEFIBRILLATORS
    • Table 30 GLOBAL HOME DEFIBRILLATOR MARKET, THROUGH 2012 ($ MILLIONS)
      • MONITORS AND SENSORS
    • Table 31 MARKET FOR HOME MONITORING DEVICES, THROUGH 2012 ($ MILLIONS)
    • Figure 24 TRENDS IN HOME MONITORING EQUIPMENT SHARES BY TYPE OF EQUIPMENT, 2006-2012 (PERCENT OF TOTAL RESPIRATORY HME SALES)
    • Figure 25 TRENDS IN HOME MONITORING DEVICES MARKET SHARES BY GEOGRAPHICAL MARKET, 2006-2012 (PERCENT OF TOTAL HOME MONITOR SALES)
      • Glucose Monitors
    • Table 32 MARKETS FOR GLUCOSE SELF-MONITORING DEVICES, THROUGH 2012 ($ MILLIONS)
    • Table 32 (CONTINUED)
      • Blood Pressure Monitors
    • Table 33 MARKETS FOR HOME BLOOD PRESSURE MONITORS, THROUGH 2012 ($ MILLIONS)
    • Table 33 (CONTINUED)
      • Apnea and Other Types of Sleep Monitors
    • Table 34 SLEEP APNEA MONITOR MARKET, 2006-2012 ($ MILLIONS)
      • Cholesterol Monitors
    • Table 35 CHOLESTEROL MONITOR MARKET, THROUGH 2012 ($ MILLIONS)
      • Fetal Monitors
    • Table 36 HOME FETAL MONITOR MARKET, THROUGH 2012 ($ MILLIONS)
      • Peak Flow (Asthma) Monitors
    • Table 37 GLOBAL ASTHMA MONITOR MARKET, THROUGH 2012 ($ MILLIONS)
      • Home ECG Monitors
    • Table 38 GLOBAL HOME ECG MONITOR MARKET, THROUGH 2012 ($ MILLIONS)
      • TELEMETRY DEVICES
    • Figure 26 HOME TELEMETRY DEVICE SALES BY GEOGRAPHICAL MARKET, 2006 (PERCENT OF TOTAL SALES)
    • Table 39 GLOBAL MARKET FOR HOME TELEMETRY DEVICES, THROUGH 2012 ($ MILLIONS)
      • OTHER TYPES OF HME
    • Table 40 GLOBAL MARKET FOR LYMPHEDEMA PUMPS, THROUGH 2012 ($ MILLIONS)
  • Chapter 4 - PATENT ANALYSIS
    • Table 41 U.S. HME PATENTS ISSUED SINCE 1975
    • Figure 27 U.S. HME PATENTS ISSUED SINCE 1975 (%)
    • Figure 28 LARGEST HME PATENT HOLDERS (PERCENT OF TOTAL HME PATENTS ISSUED THROUGH 10/1/2007)
  • Chapter 5 - COMPANY PROFILES
    • A&D MEDICAL/LIFESOURCE
    • ABBOTT LABORATORIES, INC.
    • ALLIED HEALTH CARE PRODUCTS, INC.
    • ANALOGIC INC.
    • ARADIGM CORP.
    • ARITHMED GMBH
    • BAXTER INTERNATIONAL, INC.
    • BAYER DIAGNOSTICS
    • CARD GUARD AG
    • ENERGY-LAB TECHNOLOGIES GMBH
    • T+MEDICAL
    • FRESENIUS MEDICAL CARE AG & CO. KGAA
    • HEALTH FRONTIER, INC.
    • HOME DIAGNOSTICS INC.
    • HOMMED LLC
    • INVACARE CORP.
    • LIFESCAN, INC
    • MEDLINE INDUSTRIES, INC.
    • MEDTRONIC MINIMED
    • MEDVITAL
    • NXSTAGE MEDICAL, INC.
    • NIR DIAGNOSTICS INC
    • NONIN MEDICAL, INC.
    • OMRON HEALTHCARE, INC.
    • P2P HEALTH SYSTEMS, INC.
    • PARI PHARMA
    • PENDRAGON MEDICAL LTD.
    • PFIZER INC.
    • PHILIPS MEDICAL SYSTEMS
    • POLYMER TECHNOLOGY SYSTEMS
    • PREMD INC.
    • PRIDE MOBILITY PRODUCTS CORP.
    • PULSE METRIC INC.
    • RESMED, INC.
    • RESPIRONICS, INC.
    • ROCHE DIAGNOSTICS
    • RTX TELECOM A/S
    • SCOTTCARE CORP.
    • SENSATEX INC.
    • SENSITRON INC.
    • SONTRA MEDICAL CORP.
    • TELZUIT MEDICAL TECHNOLOGIES, INC.
    • VECTURA GROUP PLC
    • VIVOMETRICS INC.
    • VIVOMETRICS INC. (CONTINUED)
Back to Top